Centre Hospitalier De Brive

The medical center is at the forefront of research in sepsis and its cardiovascular implications, particularly focusing on septic cardiomyopathy. The institution is exploring innovative therapeutic strategies to manage organ failure in patients experiencing fluid-filled septic shock, stabilized under vasopressor support.

• Septic Cardiomyopathy
• Organ Failure Management
• Vasopressor Support

Through rigorous clinical trials, the center is advancing the understanding of how adjunctive therapies, such as dobutamine infusion, can improve patient outcomes in critical care settings.

Specializing in the treatment of catheter-related bloodstream infections caused by Staphylococcus aureus, the center is pioneering research into alternative antimicrobial therapies. The focus is on evaluating the efficacy of single-dose intravenous treatments compared to traditional multi-day antibiotic regimens.

• Staphylococcus aureus Infections
• Antimicrobial Resistance
• Intravenous Therapy Innovations

By conducting comparative studies, the center aims to establish new standards in infection management, potentially reducing treatment duration and improving patient compliance.

The center is a leader in the field of chronic myeloid leukemia (CML), focusing on the discontinuation of tyrosine kinase inhibitors (TKIs) and its impact on the immune system. Research efforts are directed towards optimizing treatment strategies to enhance the probability of successful TKI discontinuation.

• Chronic Myeloid Leukemia
• Tyrosine Kinase Inhibitors
• Immune System Modulation

Through innovative clinical trials, the center is contributing to the development of personalized treatment plans that aim to improve long-term outcomes for CML patients.